Allergic Proctocolitis: Literature Review and Proposal of a Diagnostic-Therapeutic Algorithm

Simona Barni1, Francesca Mori1, Mattia Giovannini1,2

  • 1Allergy Unit, Meyer Children's Hospital IRCCS, 50139 Florence, Italy.

Life (Basel, Switzerland)
|September 28, 2023
PubMed

Insights

Allergic proctocolitis (AP), a non-IgE-mediated food allergy in infants, presents with blood in stool. Diagnosis involves food elimination and reintroduction, with most infants outgrowing the allergy by one year.

Area of Science:

  • Pediatric Allergy and Immunology
  • Gastroenterology
  • Clinical Nutrition

Background:

  • Allergic proctocolitis (AP) is an increasingly recognized non-IgE-mediated food allergy in infants.
  • Clinical signs include hematochezia in otherwise healthy, thriving infants, often starting in early infancy.
  • Cow's milk protein is the most common trigger, but other allergens like soy and egg can also be implicated.

Purpose of the Study:

  • To provide an updated review of allergic proctocolitis.
  • To offer current recommendations on epidemiology, diagnosis, and treatment.
  • To aid pediatricians, allergists, and gastroenterologists in managing AP.

Main Methods:

  • Diagnosis relies on clinical history and response to dietary elimination and challenge.
  • Symptoms typically resolve within 72-96 hours after removing the trigger food.
  • The review synthesizes current literature and clinical guidelines.

Main Results:

  • Allergic proctocolitis is a benign and self-limiting condition.
  • Most children tolerate the offending food antigen by one year of age.
  • The long-term prognosis for affected infants is excellent.

Conclusions:

  • Effective management of AP involves identifying and eliminating trigger foods.
  • Early diagnosis and appropriate dietary management lead to symptom resolution.
  • Children with AP generally have a favorable prognosis and outgrow the condition.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
348
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
181
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
164
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
145
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
207
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
474